Skip to content
Services
Data Product Development and Engineering
AI Infrastructure & Engineering
Drug Discovery Computational Services
Research Environment
Consulting
Advisory across infrastructure, data & AI strategy
Data Sourcing & Partnerships
Find, access & connect the right data
Multimodal Data Integration
Unify imaging, omics & clinical data
Data Harmonization & Curation
Standardize & align data across sources
Data Pipelines & ETL
Reproducible ingestion & transformation
Data Automation & FAIRification
Automated, FAIR-compliant data flows
Where to start
Not sure your data is AI-ready?
A fixed-scope Data Journey assessment maps the gaps before you invest in modeling.
Scalable Data Infrastructure with Cloud
Cloud-native infrastructure that scales
AI-native phenotypic profiling platform
Image-analysis infrastructure for HCS
Agentic AI Workflows
Autonomous, orchestrated AI pipelines
AI-Ready Data Architecture
Architect data for AI from the start
Where to start
Not sure your data is AI-ready?
A fixed-scope Data Journey assessment maps the gaps before you invest in modeling.
Target Identification
Evidence-weighted target prioritization
Morphological Profiling
Phenotypic signatures linked to mechanism
Small Molecule Discovery
Multi-parameter compound prioritization
Biologics Discovery & Development
Developability-aware biologics design
Biomarkers
Biomarkers that survive validation
Clinical Research
HIPAA-aligned clinical data foundations
Discovery science
From a long list to a defensible shortlist.
We weight multimodal evidence into decisions your team can defend in review.
Scientific Applications & Data Visualisations
Custom scientific apps & dashboards
AI Model Development & Deployment
Build & deploy discovery-grade models
AI Agent Assistants for Scientists
AI copilots for research teams
Agentic AI Research Environment
An orchestrated agentic research stack
Discovery science
From a long list to a defensible shortlist.
We weight multimodal evidence into decisions your team can defend in review.
Consulting
Strategic guidance across infrastructure, data & AI.
AI readiness assessment
Clarify goals, gaps and priorities.
Architecture direction
Define the right foundation for scale.
Execution roadmap
Turn ideas into clear next steps.
Where to start
Go to Consulting
Explore the offer and book an assessment.
Technology
Ardigen phenAID
Phenotypic profiling platform
Ardigen Targets
Productized target identification
Ardigen Biologics
Binder design to optimized lead
Ardigen Biomarkers
Productized biomarker discovery
Ardigen ArdiOn – AI Engine
The AI engine behind our platforms
Platforms
AI-native technologies, built for discovery.
Productized platforms powered by Ardigen's proprietary AI engine and the AI-LAB loop.
Career
About us
Knowledge hub
Knowledge hub
Knowledge hub
News
Blog
Webinars
Case Studies
Publications
Posters
Topic
Target ID
Small Molecules
Clinical Drug Development
AI & ML
Bioinformatics
Software Engineering
Data Management
Bioinformatics Workflows
Phenotypic Screening
AI for Biologics
Search
Blog
Blog
17 September 2026
When the checker gets fooled: A framework for evaluating AI Agents
Blog
2 September 2026
How Agentic AI is closing the loop in drug discovery
Blog
19 August 2026
Next-Generation Tools in Drug Discovery
Blog
5 August 2026
Data Governance in Drug Discovery: Designing Audit-Ready Storage for Regulated R&D
Blog
8 July 2026
Foundation Models in Drug Discovery: What Pharma Needs to Scale Multimodal AI
Blog
25 June 2026
Knowledge Graphs in Drug Discovery: Bringing Context to Internal Data Assets
Blog
10 June 2026
How BBB-Penetrating Antibodies Cross the Blood-Brain Barrier
Blog
,
News
27 May 2026
What 4 Life Sciences Conferences Revealed About AI in Drug Discovery
Blog
27 May 2026
Scaling AI in Life Sciences: Why Data Infrastructure Determines Success
Blog
15 May 2026
The 49% Problem: Why Closing the Lab-AI Loop Starts Beneath the Iceberg
Blog
25 March 2026
End to End Data-to-Decision Journey for AI-Driven Phenomics in Drug Discovery
Blog
11 March 2026
Target Identification: From Poor Data to Quality Predictions
Blog
25 February 2026
What Are Common Data Sourcing Patterns in Pharmaceutical Research (part 3)
Blog
25 February 2026
What Type Of Data Do You Need For AI Drug Discovery (part 2)
Blog
25 February 2026
Why Data Quality Matters in AI-powered Drug Discovery (part 1)
Blog
17 February 2026
A practical 2026 roadmap for adopting AI in biopharma R&D
Blog
5 February 2026
The invisible bridge: How UX design can support AI success in bioinformatics?
Blog
28 January 2026
Data Privacy Day 2026: Why Data Privacy Is Becoming a Technical Constraint in Biotech AI
Page
1
Page
2
Page
3
Page
4
Page
5
13211